These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816 [TBL] [Abstract][Full Text] [Related]
45. The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds. Tramontano E Mini Rev Med Chem; 2008 Oct; 8(12):1298-310. PubMed ID: 18855743 [TBL] [Abstract][Full Text] [Related]
46. Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase. Lesburg CA; Radfar R; Weber PC Curr Opin Investig Drugs; 2000 Nov; 1(3):289-96. PubMed ID: 11249710 [TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research. Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620 [TBL] [Abstract][Full Text] [Related]